Status:
RECRUITING
Impact of a Biophoton Therapy on Patients With Brain Disorders
Lead Sponsor:
First Institute of All Medicines
Conditions:
Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Previous clinical studies revealed that the newly developed biophoton therapy has been safe and effective in treating patients with Alzheimer's disease, dementia, stroke, traumatic brain injury, or Pa...
Detailed Description
The participant will live in the hotel-like research center for 4 weeks, or 6 weeks if the participants are randomly placed in a placebo group. The initial 2 weeks of participation is triple blinded t...
Eligibility Criteria
Inclusion
- Must meet conditions for approval.
- Must be 18-years or older and stay in a hotel.
- Must have a caregiver willing to support the participant's full involvement in the study. • The caregiver can assist in completing all study surveys.
- Can provide informed consent or can be assisted by caregiver.
- Can provide a clinical diagnosis of a brain disorder.
- Can complete all study procedures during the study.
- Must be fluent in English (or the Caregiver can fully translate).
- Women of childbearing age must provide results of a pregnancy test in order to participate.
Exclusion
- Any untreated mental illnesses, that would affect study participation. This will be judged by the caregiver, or by the clinical study medical expert.
- Someone that relies on a ventilator.
- Someone who has a deep brain stimulator, pacemaker, or any implanted electronic devices.
- Co-morbid conditions that would interfere with study activities or response to treatment, which may include severe chronic pulmonary disease, history of uncontrolled seizures, acute or chronic infectious illness, severe diabetes, kidney failure, or any end-of-life prognosis.
- Is participating in another investigational drug or device trial.
- Has an active infectious disease, such as COVID-19.
- Pregnant women.
Key Trial Info
Start Date :
November 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 8 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06147999
Start Date
November 8 2023
End Date
November 8 2026
Last Update
August 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001
Butler, Pennsylvania, United States, 16001